HSE have published their latest bulletins:
CLP
- ECHA public consultation: call for comments (Deadline: 19 January 2024)
The Great Britain Mandatory Classification and Labelling (GB MCL) process includes the consideration of information gathered from public consultations, conducted by HSE or international bodies such as the European Chemicals Agency (ECHA).
ECHA has announced public consultations on the following proposals for harmonised classification and labelling (CLH):
- ethylene bis[3,3-bis(3-tert-butyl-4-hydroxyphenyl)butyrate] (EC: 251-073-2; CAS: 32509-66-3). Chemical registered under REACH. Health hazard class open for commenting.
- metam-sodium (ISO); sodium methyldithiocarbamate [1]; metam-potassium (ISO); potassium methyldithiocarbamate [2] (EC: 205-293-0 [1]; 205-292-5[2]; CAS: 137-42-8[1] 137-41-7[2]). Pesticide active substance. All hazard classes open for commenting.
- methyl isothiocyanate (EC: 209-132-5; CAS: 556-61-6). Metabolite of pesticide active substance. All hazard classes open for commenting.
- tebuconazole (ISO) (EC: 403-640-2; CAS: 107534-96-3). Pesticide and biocide active substance. Health hazard classes open for commenting.
View the consultation on the ECHA website
UK-based businesses with an interest in the proposal are strongly encouraged to share any relevant information. Scientific and technical information should be submitted directly to ECHA using their commenting webform by 19 January 2024. Comments will be published on ECHA’s website.
If your business is affected by the GB CLP Regulation, please also consider if you are likely to be affected by the classification and labelling proposal and let us know at an early stage if you anticipate any significant impacts or benefits.
Information on wider policy and impact considerations can be submitted to HSE at GBCLP.GBMCL@hse.gov.uk.
Under the GB CLP Regulation, HSE will consider all published opinions of the Committee of Risk Assessment of ECHA (RAC) before publishing its own Agency Technical Reports and Agency Opinions, so any information you provide will be important in any final GB MCL decision. More information on the new GB MCL system is available on the HSE website.
- Publication of GB MCL technical reports
A GB MCL technical report is an independent scientific evaluation of the information submitted under the stand-alone GB MCL process or as part of the EU harmonised classification and labelling process.
It sets out whether there is adequate scientific evidence to support a new or revised GB MCL of a substance and what that GB MCL should be.
The next batch of GB MCL technical reports is now available for download at the end of the GB MCL publication table (.xlsx).
These GB MCL technical reports relate to substances for which the RAC published a RAC Opinion under Article 37(4) of EU CLP during 2023, based on information submitted under the EU CLP Regulation. The scientific information supporting the RAC Opinion is evaluated under the GB MCL system.
At the time of publication, the classification and labelling proposed in these technical reports has not been agreed and/or adopted in Great Britain.
For information on the next steps in the process, please see our webpage on the GB MCL system. We expect to publish our next batch of technical reports in March 2024. CLP ebulletin alerts will be issued when technical reports are published on the HSE website. If you have any questions or feedback on the GB MCL technical reports, please contact us at: GBCLP.GBMCL@hse.gov.uk Journalists should contact HSE’s press office for further information.
Biocides
- New EU active substance renewal decision (New expiry date)
Following evaluation under the EU BPR, a decision has been taken to renew the active substance listed below with the following new expiry date. This affects NI:
- 1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole (Propiconazole) (CAS 60207-90-1 EC 262-104-4) in product type 08 (30 November 2030)
Take action to remain on the EU Article 95 List
If you are an EU Article 95 supplier of any of the active substance/product type combinations listed above, you must submit all the data, or a letter of access to all the data, relevant for the renewal by 12 December 2024 to remain on the list.
Check the impact on your products: If you supply biocidal products containing this active substance in the relevant product type in NI, you should check the renewal conditions to see how you may be impacted. There may be new conditions that you need to take account of when applying for product authorisation or renewal under EU BPR, or product approval under the Control of Pesticides Regulations (COPR).
You may even need to make a change to your existing authorisation or approval to comply with the renewal conditions. Some conditions may mean we need to contact you about cancelling or revoking your product authorisation or approval. In such cases, you will have an opportunity to submit comments or additional information and we will take account of these when finalising our decision.
- New EU active substance non-approval decisions: Biocidal products must be phased off the NI market
Following evaluation under the EU BPR, a decision has been taken not to approve the following active substance/product type combination. This will affect NI:
Biocidal products containing this active substance in the relevant product type can no longer be:
- supplied in NI after 19 December 2024; or
- used in NI after 19 June 2025
You must manage your stocks of the affected products to ensure they are removed from the NI supply chain by 19 December 2024.
New treated articles containing this active substance in the relevant product type cannot enter the supply chain or be imported into NI after 16 June 2024. Treated articles that have entered NI supply chains before this date can continue to be supplied and used.
Find out more about treated articles
Any affected NI product approvals under the COPR will be revoked in line with the above dates. If you are aware of any disproportionate negative impacts that are likely to arise from the non-approval of any of the active substance/product type combinations listed above, please contact us.
- Upcoming EU active substance expiry dates
Biocidal products must be phased off the NI market
The active substance/product type combinations listed below are due to expire under the EU BPR on the following dates. This affects NI:
- (RS)-4-hydroxy-3-(3-oxo-1-phenylbutyl)coumarin (Warfarin) (CAS 81-81-2 EC 201-377-6) in product type 14(deadline: 30 June 2024)
- Polyhexamethylene biguanide hydrochloride with a mean number-average molecular weight (Mn) of 1600 and a mean polydispersity (PDI) of 1.8 (PHMB (1600;1.8)) (CAS 27083-27-8 / 32289-58-0 EC 608-042-7) in product types 02, 03 and 11 (deadline: 30 June 2024)
Once the approvals expires, the active substances can no longer be used in biocidal products or treated articles of the relevant product types in NI.
If you hold an affected EU BPR product authorisation or COPR product approval, we will contact you about cancelling or revoking your authorisation or approval. You will have an opportunity to submit comments or additional information and we will take account of these when finalising our decision. If you are aware of any disproportionate negative impacts that are likely to arise from the expiry of any of the active substance/product type combinations listed above, please contact us.
- (RS)-4-hydroxy-3-(3-oxo-1-phenylbutyl)coumarin (Warfarin) (CAS 81-81-2 EC 201-377-6) in product type 14(deadline: 30 June 2024)
